April 2024

MILAN, April 2, 2024 /PRNewswire/ — Tethis S.p.A., a pioneer in the development of an innovative platform for liquid biopsy testing, is pleased to announce the enrollment of the first two patients in the clinical study TET-22-001. This study, titled “Feasibility evaluation of See.d pre

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: